Fundz

Compass Pathways To Advance Psilocybin Therapy With Up To $285M In New Financing

PUBLIC · CMPSAug 18, 2023

Round Type

Funding Round

LondonBiotechnologyHealth Care

Description

COMPASS Pathways, a London-based, Nasdaq-listed biotechnology company working in the field of mental health treatment via psilocybin therapy, is poised to raise up to $285 million in a private placement financing round.

Quick answer

COMPASS Pathways raised an undisclosed amount in a Funding Round round, dated August 18, 2023. COMPASS Pathways is based in London, England, United Kingdom.

How much did COMPASS Pathways raise?
COMPASS Pathways raised an undisclosed amount in a Funding Round round on August 18, 2023.
What does COMPASS Pathways do?
Compass Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
Where is COMPASS Pathways based and how big is it?
COMPASS Pathways is based in London, England, United Kingdom.
Who are the decision-makers at COMPASS Pathways?
Fundz holds 1 contact at COMPASS Pathways. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as COMPASS Pathways that raised within 45 days of this round, from Fundz verified event records.

  • Piccolo Medical raised $5.5M (Series B) on October 2, 2023.
  • PanTheryx, Inc. raised $52M on October 2, 2023.
  • Flat Medical raised an undisclosed amount (Series C) on October 2, 2023.
  • Amicus Therapeutics raised an undisclosed amount (Funding Round) on October 2, 2023.
  • Deka Biosciences, Inc. raised $20M (Series B) on September 28, 2023.
  • RedHill Biopharma Ltd raised $4M (Seed) on September 28, 2023.

Who to call at COMPASS Pathways, and when

A new round usually means COMPASS Pathways is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day COMPASS Pathways raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at COMPASS Pathways, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at COMPASS Pathways. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

COMPASS Pathways

Location

London, England, United Kingdom

About

Compass Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is focused on improving the lives of those who are living with mental health challenges.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment COMPASS Pathways raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for COMPASS Pathways's next move

See what Strategic adds

COMPASS Pathways raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.